Taken together, these data suggest that rTMD1 confers general anti‐inflammatory, pro‐repair benefits and, in the diabetic cornea, specifically corrects hyperglycemia‐sensitive HMGB1/TLR4/NLRP3 signaling to facilitate reepithelialization. Here, NLRP3 is linked to Hyperglycemia.